Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$21,523,773
+$21,057,775 QoQ
Shares Held
17,945
+2895.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#856
of 4,605 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EAGLE GLOBAL ADVISORS LLC holds $90,990,326 across 10 Drug Manufacturers - General names. LLY ranks #2 (23.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,170 | $22,646,504 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
17,945 | $21,523,773 | |
| 3 | ABBV |
AbbVie Inc.
|
79,227 | $19,936,682 | |
| 4 | MRK |
Merck & Co., Inc.
|
138,101 | $17,745,978 | |
| 5 | AZN |
Astrazeneca PLC
|
37,609 | $7,131,418 | |
| 6 | AMGN |
Amgen Inc
|
1,640 | $593,876 | |
| 7 | BIIB |
Biogen Inc.
|
2,609 | $563,700 | |
| 8 | PFE |
Pfizer Inc
|
13,800 | $332,304 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,523,773 | 17,945 | Shares | Sole | 2026-07-30 | |
| 2024-03-31 | $465,998 | 599 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $276,887 | 475 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $264,267 | 492 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $235,427 | 502 | Shares | Sole | 2023-07-21 | |
| No filing history on record for this holder in this stock. | ||||||